Table of Content


Chapter 1   Methodology and Scope
1.1    Market scope and definitions
1.2    Research design
1.2.1    Research approach
1.2.2    Data collection methods
1.3    Base estimates and calculations
1.3.1    Base year calculation
1.3.2    Key trends for market estimation
1.4    Forecast model
1.5    Primary research and validation
1.5.1    Primary sources
1.5.2    Data mining sources
Chapter 2   Executive Summary
2.1    Industry 360? synopsis
Chapter 3   Industry Insights
3.1    Industry ecosystem analysis
3.2    Industry impact forces
3.2.1    Growth drivers
3.2.1.1    Rising prevalence of chronic diseases
3.2.1.2    Advancements in AI and Machine learning
3.2.1.3    Adoption of wearable devices
3.2.1.4    Growing focus on remote monitoring
3.2.2    Industry pitfalls and challenges
3.2.2.1    High costs of advanced devices
3.2.2.2    Lack of skilled professionals
3.3    Growth potential analysis
3.4    Regulatory landscape
3.5    Technological landscape
3.6    Future market trends
3.7    Porter’s analysis
3.8    PESTEL analysis
Chapter 4   Competitive Landscape, 2024
4.1    Introduction
4.2    Company market share analysis
4.3    Company matrix analysis
4.4    Competitive analysis of major market players
4.5    Competitive positioning matrix
4.6    Strategy dashboard
Chapter 5   Market Estimates and Forecast, By Type, 2021 – 2034 ($ Mn)
5.1    Key trends
5.2    Wearable
5.3    Mobile based applications
5.4    Sensors
5.5    Others types
Chapter 6   Market Estimates and Forecast, By Clinical Practice, 2021 – 2034 ($ Mn)
6.1    Key trends
6.2    Diagnostic digital biomarkers
6.3    Monitoring digital biomarkers
6.4    Predictive and prognostic digital biomarkers
6.5    Other clinical practices
Chapter 7   Market Estimates and Forecast, By Therapeutic Area, 2021 – 2034 ($ Mn)
7.1    Key trends
7.2    Cardiovascular and metabolic disorders (CVMD)
7.3    Diabetes
7.4    Respiratory disorders
7.5    Psychiatric disorders
7.6    Sleep and movement diseases
7.7    Neurological disorders
7.8    Musculoskeletal disorders
7.9    Other therapeutic areas
Chapter 8   Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)
8.1    Key trends
8.2    Healthcare providers
8.3    Payers
8.4    Pharmaceutical and biotechnology companies
8.5    Academic and research institutions
Chapter 9   Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
9.1    Key trends
9.2    North America
9.2.1    U.S.
9.2.2    Canada
9.3    Europe
9.3.1    Germany
9.3.2    UK
9.3.3    France
9.3.4    Spain
9.3.5    Italy
9.3.6    Netherlands
9.4    Asia Pacific
9.4.1    China
9.4.2    Japan
9.4.3    India
9.4.4    Australia
9.4.5    South Korea
9.5    Latin America
9.5.1    Brazil
9.5.2    Mexico
9.5.3    Argentina
9.6    Middle East and Africa
9.6.1    South Africa
9.6.2    Saudi Arabia
9.6.3    UAE
Chapter 10   Company Profiles
10.1    ActiGraph
10.2    AliveCor
10.3    Altoida
10.4    Amgen Inc.
10.5    Adherium Limited
10.6    Aural Analytic
10.7    Brainomix
10.8    Biogen
10.9    Clario
10.10    Empatica Inc.
10.11    Evidation Health Inc.
10.12    IXICO plc
10.13    Koneksa
10.14    Sonde Health, Inc.
10.15    Vivo Sense